Risk assessment and primary prevention of VTE in patients with cancer: Advances, challenges, and evidence gaps
Authors:
Open Access
- 28 May 2022
- journal article
- research article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 35 (1) , 101347
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical PatientsNew England Journal of Medicine, 2013
- Prevention of VTE in Nonorthopedic Surgical PatientsChest, 2012
- Prevention of VTE in Nonsurgical PatientsChest, 2012
- Validation of the Caprini Risk Assessment Model in Plastic and Reconstructive Surgery PatientsJournal of the American College of Surgeons, 2011
- Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized studyJournal of Thrombosis and Haemostasis, 2010
- Risk factors for post‐thrombotic syndrome in patients with a first deep venous thrombosisJournal of Thrombosis and Haemostasis, 2008
- Development and validation of a predictive model for chemotherapy-associated thrombosisBlood, 2008
- Multivariable Predictors of Postoperative Venous Thromboembolic Events after General and Vascular Surgery: Results from the Patient Safety in Surgery StudyJournal of the American College of Surgeons, 2007
- Identifying acutely ill medical patients requiring thromboprophylaxisJournal of Thrombosis and Haemostasis, 2006
- PREVENTION OF FATAL POSTOPERATIVE PULMONARY EMBOLISM BY LOW DOSES OF HEPARIN *1An International Multicentre TrialThe Lancet, 1975